NEW YORK, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the presentations from the Life Sciences Virtual Investor Forum held September 19th are now available for online viewing. This event was co-sponsored by Zacks Small-Cap Research.

REGISTER NOW AT: https://bit.ly/3TuSFdy

The company presentations will be available 24/7 for 90 days. Investors, advisors, and analysts may download
investor materials from the company’s resource section.

Select companies are accepting 1x1 management meeting requests through September 24th.

September 19th

PresentationTicker(s)
VolitionRX LimitedNYSE American: VNRX
Genflow Biosciences PlcOTCQB: GENFF | LSE: GENF
Aprea Therapeutics, Inc.Nasdaq: APRE
Chromocell Therapeutics Corp.NYSE American: CHRO
BioVaxys Technology Corp.OTCQB: BVAXF | CSE: BIOV
Protalix BioTherapeutics, Inc.NYSE American: PLX
Acasti Pharma Inc.Nasdaq: ACST
Aethlon Medical, Inc.Nasdaq: AEMD
Unicycive Therapeutics, Inc.Nasdaq: UNCY
Evaxion Biotech A/SNasdaq: EVAX
Adaptimmune Therapeutics plcNasdaq: ADAP


To facilitate investor relations scheduling and to view a complete calendar of Virtual Investor Conferences, please visit www.virtualinvestorconferences.com.

About Virtual Investor Conferences®

Virtual Investor Conferences (VIC) is the leading proprietary investor conference series that provides an interactive forum for publicly traded companies to seamlessly present directly to investors.

Providing a real-time investor engagement solution, the VIC is specifically designed to offer companies more efficient investor access. Replicating the components of an on-site investor conference, VIC offers companies enhanced capabilities to connect with investors, schedule targeted one-on-one meetings and enhance their presentations with dynamic video content. Accelerating the next level of investor engagement, Virtual Investor Conferences delivers leading investor communications to a global network of retail and institutional investors.

Media Contact: 
OTC Markets Group Inc. +1 (212) 896-4428, media@otcmarkets.com

Virtual Investor Conferences Contact:
John M. Viglotti
SVP Corporate Services, Investor Access
OTC Markets Group
(212) 220-2221
johnv@otcmarkets.com


Primary Logo